Skip to main content
The American Journal of Tropical Medicine and Hygiene logoLink to The American Journal of Tropical Medicine and Hygiene
. 2022 Oct 10;107(5):1132–1136. doi: 10.4269/ajtmh.22-0388

Retrospective Characterization of Noma Cases Found Incidentally across Nigeria during Outreach Programs for Cleft Lip from 2011–2020

Ngutor Ver-or 1,*, Chukwuemeka Kenneth Iregbu 2, Olaniyi Olufemi Taiwo 3, Ikhelua Thomas Afeleokhai 1, Chiangi Gabriel Aza 1, Jeremiah Z Adaji 1, Charlse Margima 1
PMCID: PMC9709002  PMID: 36216317

ABSTRACT.

Reports of cases of noma in Nigeria remain scarce despite its known and devastating effects on victims. This report presents a retrospective cross-sectional study based on data regarding on patients with noma encountered incidentally during Oral Health Advocacy Initiative outreach on orofacial diseases across 34 states and the Federal Capital Territory in Nigeria over 10 years (2011–2020), which was aimed at contributing to an understanding of the epidemiology of noma in Nigeria. The data were collated and analyzed, and are presented in frequency distribution tables and charts. A total of 7,195 patients with noma were encountered. The northeastern region had the greatest number of patients (n = 1,785, 24.8%) whereas the southwestern region had the least (n = 196, 2.7%). When aggregated by state, Ondo State had the least number of patients (n = 31, 0.4%) whereas Kano State had the greatest (n = 623, 8.7%). Patient age ranged from 3 to 70 years, with a slight male preponderance (56.9%). This report highlights the fact that noma is prevalent in Nigeria but remains neglected, with extensive but preventable physical, emotional, and social debilitation and devastation of the victims across all age groups. There is a need for a more robust survey to determine the true burden of the disease. There is also an urgent need for collaboration between governments and nongovernmental organizations to institute appropriate interventions by way of public education and enlightenment, as well as case detection and early treatment to mitigate the devastating consequences of delayed or poorly managed cases.

INTRODUCTION

Noma, otherwise called stomatitis gangrenosa or cancrum oris, is a debilitating infectious disease that attacks the orofacial complex, destroying the oral and para-oral structures, and resulting in dehumanizing orofacial gangrene, which may involve the mandible, maxilla, and occasionally the nose, extending to the infraorbital margins.1,2 Etymologically, noma has its origin from the Greek word “nomein,” meaning “to devour,” and was first reported by Hippocrates in about 5th century bc.3 Although noma is considered an infectious disease, the exact causative microorganisms remain unclear.24

The disease affects all ages, but mostly children 2 to 6 years of age. Those who survive have severe facial disfigurements and multiple functional impairments, including difficulties eating, seeing, and breathing, which contributes to stigmatization.5 The disease progresses through unique clinical stages, beginning at the reversible and seemingly inconsequential necrotizing gingivitis/edema stages to the grotesque gangrenous stage associated with extensive soft and hard tissue necrosis, often within a week.1,2 Noma is classified into six stages: stage 0, simple gingivitis; stage 1, acute necrotizing ulcerative gingivitis; stage 2, edema; stage 3, gangrene; stage 4, scarring; and stage 5, sequelae.6

Noma is an opportunistic infection associated with an imbalance of microorganisms of the oral flora.7 Studies have associated noma with poverty and the impoverished regions of the world, especially sub-Saharan Africa, informing the name noma belt region.2 Although this disease has been present in Europe since ancient times, it is now reported mainly in Africa and occasionally in Latin America and Asia.1,3 With improvements in hygiene and nutritional status, and the decline in measles outbreaks and other eruptive fevers, noma disappeared from more developed countries,8,9 but reappeared during World War II in concentration camps and in the Netherlands, where the population suffered from real famine in the winter of 1944 and 1945.9

Without treatment, approximately 90% of patients with noma die within 1 or 2 weeks because of sepsis.10 The small percentage of survivors generally suffers from severe sequelae, such as facial mutilation, trismus, oral incontinence, and speech problems.11 Treatment with antibiotics, wound debridement, and nutritional support in patients seen early will greatly reduce mortality and morbidity.5 Noma can become inactive with or without treatment, and patients can survive into adulthood, but often require extensive reconstructive surgery and physiotherapy to ameliorate the resulting defects and improve function.6,12

Epidemiologically, the true global incidence of noma is unknown. However, alarming reports have been published in extant literature by Bourgeois and Leclercq10 and Farley et al.,12 indicating that the magnitude of the noma problem in the world may not yet have been recognized sufficiently. This challenge is still unabated. The explanation is that noma occurs among the poorest in the poorest societies, who do not have access to proper health care and adequate nutrition.

Research targeted at determining the incidence and prevalence of noma constitutes a central feature of public health action against the disease.2 Reports estimate a range from 30,000 to 140,000 individuals as the annual global incidence.7,11,13 A few studies and reports in Nigeria have shown varied incidence and prevalence of noma in the past two decades, including the three patients in 10 years reported by Oji14 in Enugu, a prevalence of 6.4 per 1,000 population reported from a study in the northeast by Fieger et al.,11 and a prevalence of 7 per 1,000 from a hospital-based study in Ibadan by Denloye et al.15 Bello et al.2 reported a prevalence rate of 8.3 to 100,000 (0.083 per 1,000 population) from their outreach in the north–central zone of the country, whereas Farley et al.12 documented a 3.3% prevalence rate from another study in northeastern Nigeria.

The Oral Health Advocacy Initiative (OHAI) has been carrying out outreach programs across the nation from 2011 to date to identify and correct cleft lip and palate malformations surgically. Advertisements, community mobilization, and invitations for free surgical correction for individuals with cleft lip and palate attracted patients with noma for treatment. This report describes the findings from such patients with noma, spanning a period of 10 years (2011–2020).

METHODS

This is a retrospective cross-sectional study based on data on patients with noma encountered incidentally during OHAI outreach on orofacial disease across 34 states and the Federal Capital Territory in Nigeria for 10 years (2011–2020). These patients presented at OHAI outreach camps across the country. The data were collected at the state level and pooled to form the subnational data set used.

Inclusion and exclusion criteria were used to define patients used for the report. The inclusion criteria included patients with orofacial infection with orofacial deformity that was not present at birth and patients with established orofacial deformities (sequelae) that started with an infective process. Exclusion criteria were as follows: orofacial deformities present at birth or a result of other noninfective causes, such as trauma and cleft lip and palate, and orofacial infections without any deformities.

For clinical diagnosis, basically, patients must not have been born with the facial manifestation that would have started as an infection. Patients were categorized based on the location of the lesion: the left cheek, left angle, left cheek and angle, right cheek, right cheek and angle, right angle, upper lip, and lower lip. Other information recorded include patients’ biographical data, whether they were able to open their mouth, immunization history, and tooth brushing/cleansing habits. Patients’ level of oral health education, knowledge of nutrition, information on feeding habits, onset of lesion, and experiences preceding and succeeding the lesion occurrence were also documented.

Data were analyzed using the IBM Statistical Package for the Social Sciences (version 25; (IBM Corp., Armonk, NY). The results are presented as frequency distribution tables and charts.

Informed consent was obtained from participants and ethical clearance was obtained from the National Hospital Abuja Ethics Committee (reference no. NHA/EC/084/2021).

RESULTS

Demographic characteristics of subjects.

A total of 7,195 patients with noma were encountered across 34 states and the Federal Capital Territory of Nigeria (see Supplemental Material Appendix S1). As shown in Table 1, patient age ranged from 3 to 70 years; 1,186 (16.5%) were younger than 10 years, 1,796 (25%) were 10 to 30 years, 2,853 (39.7%) were 31 to 50 years, and 1,360 (18.9%) were 50 years or older. There was a slight male predominance (n = 4,094, 56·9%), 4,460 (62%) were farmers, 3,488 (48.5%) had no education at all, 2,408 (33.4%) had completed the primary level of education, and 131 (1.8%) attained the tertiary level of education.

Table 1.

Demographic characteristics of patients with noma

Characteristic n %
Gender
 Male 4,094 56.9
 Female 3,101 43.1
Occupation
 Farming 4,460 62.0
 Civil servant 140 1.9
 Student 605 8.4
 Housewife 917 12.7
 Pupil 856 11.9
 Other 217 3.0
Education
 None 3,488 48.5
 Koranic 319 4.4
 Primary 2,408 33.5
 Secondary 849 11.8
 Tertiary 131 1.8
Age, years
 < 10 1,186 16.5
 10–30 1,796 25.0
 31–50 2,853 39.7
 > 50 1,360 18.9
Total 7,195 100.0

Sites of tissue lesions.

The soft tissue lesions involved multiple sites. As shown in Figure 1, the right cheek and angle were affected in 1,909 patients (26.5%), the left angle in 1,052 (15.6%), and the left cheek in 1,045 (14.5%). The upper lip was involved in 784 patients (10.9%) and the lower lip in 721 (10%). A total of 5,979 (83.1%) patients were still able to open their mouth despite the lesions, whereas 1,216 (16.9%) were affected by trismus.

Figure 1.

Figure 1.

Frequency of location of lesions in the orofacial region.

Table 2 shows that 5,723 patients (79.5%) reported not having any oral health education; 2,867 patients (39.8%) practice oral hygiene by rinsing their mouth with water and using their fingers; 1,279 patients (17.8%) rinse their mouth with just water; 1,352 patients (18.8%) use a toothbrush and toothpaste; 1,348 patients (18.8%) use a chewing stick, charcoal, or salt; and 349 patients (4.9%) reported no form of mouth cleaning. With regard to regularity or oral care, 3,659 patients (50.9%) cleaned their mouth occasionally, 1,338 (18.6%) cleaned their mouth once a day, and 2,198 (30.5%) cleaned their mouth twice a day.

Table 2.

Oral health hygiene and education

Oral health hygiene and education n %
Any oral health education
 Yes 1,412 19.6
 No 5,723 79.5
 Prefer not to say 60 0.8
Mouth-cleaning habits
 Rinses mouth using water 1,279 17.8
 Rinses mouth using water and fingers 2,867 39.8
 Cleans mouth using chewing stick 753 10.5
 Uses toothbrush and toothpaste 1,352 18.8
 Uses charcoal 394 5.5
 Uses salt 201 2.8
 Does not clean mouth 349 4.9
Regularity of mouth cleaning
 Occasional 3,659 50.9
 Once a day 1,338 18.6
 Twice a day 1,849 25.6
 Does not clean mouth 349 4.9
Total 7,195 100.0

A total of 6,585 patients (91.5%) have had no education in feeding and nutrition. A total of 6,537 (90.9%) consume carbohydrate-based foods more often (Table 3), and 322 (4.5%) and 336 (4.7%) reported consuming proteins and fats, respectively. Although 3,791 patients (52.7%) eat as often as food is available, 919 (12.8%) could afford only one or two meals a day.

Table 3.

Feeding and nutritional behavioral pattern of patients with noma

Behavioral Pattern n %
Any education in feeding and nutrition
 Yes 610 8.5
 No 6,585 91.5
Food mostly eaten
 Carbohydrates 6,537 90.9
 Proteins 322 4.5
 Fats 336 4.7
How often food is eaten
 Once a day 119 1.7
 Twice a day 800 11.1
 Thrice a day 2,457 34.1
 As often as food is available 3,791 52.7
 Prefer not to say 28 0.4
Total 7,195 100.0

Reactions after lesion occurrence.

Approximately 70% of the lesions started before the age of 8 years, as shown in Figure 2, whereas 10% started after the age of 16.

Figure 2.

Figure 2.

Age when lesion started.

Table 4 shows that 2,832 complications (39.4%) started as a boil, 1,809 (25.1%) as swelling, 1,712 (23.8%) as itching around the area of the lesion, and 748 (10.4%) as bleeding from the gums. Most patients embarked on self-treatment; 3,011 (41.8%) resorted to home treatment with charcoal, 951 (13.2%) opted for traditional treatment with a sacrifice, 536 (7.4%) visited patent medicine stores, 1,364 (19.0%) visited a hospital, and 1,333 (18.5%) sought no treatment. Of the 1,364 patients who sought care at a hospital, 649 (47.6%) did so within the first 3 weeks of the lesion, 239 (17.5%) within a month or two, 53 (3.9%) waited for as long as 3 months before visiting the hospital, and 253 (18.5%) waited up to 1 year before visiting a hospital.

Table 4.

Circumstances surrounding lesion occurrence

Circumstance n %
How lesion started
Boil 2,832 39.4
 Itching 1,712 23.8
 Swelling 1,809 25.1
 Bleeding from gums 748 10.4
 Measles 94 1.3
First reaction after lesion discovery
 Home treatment with charcoal 3,011 41.8
 Traditional treatment with sacrifice 951 13.2
 Went to hospital 1,364 19.0
 Visited patent medicine store for medication 536 7.4
 No treatment 1,333 18.5
How long it took to visit a hospital
 1–3 weeks 649 47.6
 1–2 months 239 17.5
 3 months 53 3.9
 > 3 months 130 9.5
 1 year 253 18.5
 > 1 year 40 2.9
What did the hospital do for you?
 I was treated 942 70.6
 I was referred to another hospital 343 25.9
 Nothing 41 3.5
Immunization history
 Incomplete immunization 3,007 41.8
 Doesn’t know 3,074 42.7
 Completed immunization schedule 611 8.5
 Refused it 503 7.0
Total 7,195 100.0

DISCUSSIONS

The total number of patients with noma found incidentally suggests the existence of a high burden of the disease across the country. This is so because the report focused only on complicated cases that were easily diagnosed clinically. When the uncomplicated or early and fatal manifestations are considered, the burden could indeed be worrisome. Noma is highly preventable, and the progression to complications and death is reversible, making the disease easily amenable to remedy. An early intervention could have prevented the numerous manifestation of trismus, and respiratory and feeding/nutritional challenges faced by some of the patients.

The majority of cases of noma began in children younger than 8 years old. This places the burden of care on parents. The low level of education of the patients coupled with extreme poverty, poor nutrition, and poor personal and environmental hygiene magnifies the risk of acquisition of the disease.2,5,1619 The settings in which the patients with noma were found demonstrates the association of the disease with poor nutritional status, poverty, low levels of education, and poor oral and environmental hygiene, as established in previous studies.2,5,1619 Most of the patients affected consumed predominantly carbohydrate-based food, suggesting that most experience protein malnutrition, which ultimately lowers the immune status.5,7,16,20,21 In the context of poor oral hygiene practices, there could be proliferation of oral flora, which may capitalize on the opportunities of likely mucosal abrasions resulting from inflammation and use of such materials as coal to invade the tissues of the mouth and set up rapidly spreading necrotic lesions. Although the true pathogens associated with noma remain unknown, it is most likely that members of the oral flora play significant roles in the pathogenesis of the disease. A properly designed study is needed to decipher the true pathogens.

The poor health-seeking behavior of the communities accentuates the impact of the disease. Inappropriate remedies were tried, and many of them were the result of poverty and lack of access to health-care facilities. Many of the early manifestations of noma, as seen in our study, are as common as many other local ailments that are often ignored or amenable to local remedies, and may explain in part the delay in seeking appropriate health-care services.

This study has revealed the existence and neglect of a highly preventable but debilitating and often fatal disease. It has added to the stock of existing but scarce data on noma, which were mainly from hospital-based or subregional studies. There is need for policymakers, nongovernmental organizations and governments to give attention to this disease by carrying out further studies to determine the actual burden and etiology of the disease, as well as to institute preventive measures such as education, nutritional support, and access to health care for early detection and treatment.

CONCLUSION

This is the first near-countrywide epidemiological report on noma, and it has revealed that noma is indeed very prevalent in Nigeria. We recommend a multifaceted approach toward tackling the scourge of this disease in our country by addressing the multiple problems of poor oral health hygiene, malnutrition, poverty, lack of access to health-care services, and poor personal and environment hygiene. Awareness should be created regarding the early manifestations of the disease and the appropriate healthy actions to be taken. Education of health workers in existing health facilities on disease identification is critical. This will facilitate proper diagnosis and referral to appropriate centers that specialize in noma treatment.

Supplemental files

Supplemental materials

tpmd220388.SD1.pdf (474.2KB, pdf)

ACKNOWLEDGMENTS

The American Society of Tropical Medicine and Hygiene (ASTMH) assisted with publication expenses.

Note: Supplemental Appendix S1 appears at www.ajtmh.org.

REFERENCES

  • 1.  Enwonwu CO Falkler WA Jr Idigbe EO , 2000. Oro-facial gangrene (noma/cancrum oris): pathogenetic mechanisms. Crit Rev Oral Biol Med 11: 159–171. [DOI] [PubMed] [Google Scholar]
  • 2.  Bello SA Adeoye JA Oketade I Akadiri OA , 2019. Estimated incidence and prevalence of noma in north central Nigeria, 2010–2018: a retrospective study. PLoS Negl Trop Dis 13: e0007574. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Baratti-Mayer et al. 2003. Noma: an “infectious” disease of unknown aetiology. Lancet Infect Dis 3: 419–431. [DOI] [PubMed] [Google Scholar]
  • 4.  Tonna JE Lewin MR Mensh B , 2010. A case and review of noma. PLoS Negl Trop Dis 4: e869. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.  Ashok N Tarakji B Darwish S Rodrigues JC Altamimi MA , 2016. A review on noma: a recent update. Glob J Health Sci 8: 53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. World Health Organization (WHO), 2016. NOMA is a severe disease It is treatable if detected and managed early! Available at: https://www.afro.who.int/sites/default/files/2017-07/Information_brochure_EN.pdf. Accessed April 18, 2022.
  • 7.  Srour ML Marck K Baratti-Mayer D , 2017. Noma: overview of a neglected disease and human rights violation. Am J Trop Med Hyg 96: 268. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.  Adelsberger L , 1946. Medical observations in Auschwitz concentration camp. Lancet 247: 317–319. [DOI] [PubMed] [Google Scholar]
  • 9. Marck KW, 2003. Noma: the face of poverty. Hannover: MIT-Verlag GmbH, 53–128. [Google Scholar]
  • 10.  Bourgeois DM Leclercq MH , 1999. The World Health Organization initiative on noma. Oral Dis 5: 172–174. [DOI] [PubMed] [Google Scholar]
  • 11.  Fieger A Marck KW Busch R Schmidt A , 2003. An estimation of the incidence of noma in north‐west Nigeria. Trop Med Int Health 8: 402–407. [DOI] [PubMed] [Google Scholar]
  • 12.  Farley E et al. 2020. The prevalence of noma in northwest Nigeria. BMJ Glob Health 5: e002141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. World Health Organization , 1998. Noma Today: A Public Health Problem? Report on an Expert Consultation According to the Delphi Method. Geneva, Switzerland: WHO. [Google Scholar]
  • 14.  Oji C , 2002. Cancrum oris: its incidence and treatment in Enugu, Nigeria. Br J Oral Maxillofac Surg 40: 406–409. [PubMed] [Google Scholar]
  • 15.  Denloye OO Aderinokun GA Lawoyin JO Bankole OO , 2003. Reviewing trends in the incidence of cancrum oris in Ibadan, Nigeria. West Afr J Med 22: 26–29. [DOI] [PubMed] [Google Scholar]
  • 16.  Adeniyi SA Awosan KJ , 2019. Pattern of noma (cancrum oris) and its risk factors in northwestern Nigeria: a hospital-based retrospective study. Ann Afr Med 18: 17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.  Marck KW De Bruijn HP , 1999. Surgical treatment of noma. Oral Dis 5: 167–171. [DOI] [PubMed] [Google Scholar]
  • 18.  Enwonwu CO , 1972. Epidemiological and biochemical studies of necrotizing ulcerative gingivitis and noma (cancrum oris) in Nigerian children. Arch Oral Biol 17: 1357–1371. [DOI] [PubMed] [Google Scholar]
  • 19.  Enwonwu CO , 1995. Noma: a neglected scourge of children in sub-Saharan Africa. Bull World Health Organ 73: 541. [PMC free article] [PubMed] [Google Scholar]
  • 20. World Health Organization , 2016. Promoting Oral Health in Africa: Prevention and Control of Oral Diseases and Noma as Part of Essential Noncommunicable Disease Interventions. Geneva, Switzerland: WHO. [Google Scholar]
  • 21.  Evering T Weiss LM , 2006. The immunology of parasite infections in immunocompromised hosts. Parasite Immunol 28: 549–565. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplemental materials

tpmd220388.SD1.pdf (474.2KB, pdf)

Articles from The American Journal of Tropical Medicine and Hygiene are provided here courtesy of The American Society of Tropical Medicine and Hygiene

RESOURCES